Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: Out of specification for dissolution.
| Brand name | MESALAMINE |
| Generic name | MESALAMINE |
| Active ingredient(s) | MESALAMINE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512 |
| NDC | 63304-089-13 |
| Full product label | Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide in the U.S. |
| Quantity | 54,960 bottles |
| Recall initiated | 2024-02-05 |
| Report date | 2024-03-06 |
| Recall completed | — |
| Recall number | D-0350-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗